MedPath

Comparison of Treatments in Venous Insufficiency

Not Applicable
Completed
Conditions
Venous Insufficiency
Interventions
Procedure: Laser ablation
Procedure: Operative treatment
Procedure: Foam sclerotherapy
Registration Number
NCT01298908
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

Randomized controlled trial, a method used to implement the random allocation sequence is numbered containers.

The aim of the study is to compare operative treatment, ultrasound guided laser ablation and ultrasound guided foam sclerotherapy in occluding/ablating of insufficiency in great saphenous trunks. On the grounds of the available data, the study hypothesis is that using laser or operative treatment more than 20 percent better outcome can be achieved compared to foam sclerotherapy.

Detailed Description

In operative treatment the great saphenous vein will be removed after flush ligation by femoral vein and stripping of the trunk. In intravenous laser treatment a thin laser fiber is inserted through a tiny distal entry point. The probe is guided into place using ultrasound and the procedure is performed under local tumescence anesthesia. Laser energy is delivered to seal the faulty vein. Ultrasound guided foam sclerotherapy involves an injection of foam (sodium tetradecyl sulfate mixed with air according to the Thessari method) directly into the venous trunk under ultrasound control. In each group patients will use supportive treatment stockings 2 weeks after treatment. The patients in all groups are followed up one year by ultrasound scanning.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
231
Inclusion Criteria
  • patients with chronic superficial vein insufficiency
  • patient must be 20-70 years old
  • degree of difficulty of vein insufficiency C2-C4
  • average diameter of refluxing great saphenous vein 4 -10 mm
  • patient is agreeable to the study
Exclusion Criteria
  • peripheral atherosclerotic occlusive disease
  • lymphoedema
  • severe concomitant disease
  • venous ulcers or unclassified skin changes
  • BMI more than 40
  • pregnancy
  • allergy to the foam used in sclerotherapy or to local anaesthetics
  • coagulation disorder
  • bilateral vein insufficiency (equal symptoms)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laser ablationLaser ablationUltrasound guided laser ablation
Operative treatmentOperative treatmentvein stripping
Foam sclerotherapyFoam sclerotherapyUltrasound guided foam sclerotherapy
Primary Outcome Measures
NameTimeMethod
Recanalization or reflux of the treated venous trunkat 1 and 12 months

Results will be verified by Duplex scanning

Secondary Outcome Measures
NameTimeMethod
Symptom reliefat 1 and 12 months

Symptoms will be evaluated by using CEAP-classification and degree of disability

Complications related to procedureat 1 and 12 months

At 1 month follow-up immediate complications will be recorded. At 12 months follow-up appearance of late complications and pain and incapacity for work due to the procedure will be recorded.

Quality of lifeat 1 and 12 months

Quality of life is evaluated with two questionnaires: Aberdeen (which is a 13-item questionnaire with categories related specially to disadvantages caused by varicose veins) and 15D (a questionnaire with categories related to general quality of life)

Trial Locations

Locations (2)

Department of Vascular Surgery, Tampere University Hospital

🇫🇮

Tampere, Finland

Department of Vascular Surgery, Helsinki University Central Hospital

🇫🇮

Helsinki, HUS, Finland

© Copyright 2025. All Rights Reserved by MedPath